Diabetic Retinopathy and Maculopathy
- PMID: 36652952
- DOI: 10.1055/a-1946-3798
Diabetic Retinopathy and Maculopathy
Conflict of interest statement
K. D. Lemmen: Lecture fees: Bayer, Novartis, Advisory Board: Novartis, Pharm-Allergan. H.-P. Hammes: Lecture fees: Novartis, Bayer, MSD, Novo Nordisk, Boehringer Ingelheim, Sanofi. B. Bertram: no conflict of interest.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical